Nakagawa, T., Sanchez-Lozada, L. G., Andres-Hernando, A., Kojima, H., Kasahara, M., Rodriguez-Iturbe, B., . . . Johnson, R. J. (2021). Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease. Front Immunol.

Nakagawa, Takahiko, Laura G. Sanchez-Lozada, Ana Andres-Hernando, Hideto Kojima, Masato Kasahara, Bernardo Rodriguez-Iturbe, Petter Bjornstad, Miguel A. Lanaspa, ja Richard J. Johnson. "Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease." Front Immunol 2021.

Nakagawa, Takahiko, et al. "Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease." Front Immunol 2021.